250 related articles for article (PubMed ID: 37244935)
1. macroH2A2 antagonizes epigenetic programs of stemness in glioblastoma.
Nikolic A; Maule F; Bobyn A; Ellestad K; Paik S; Marhon SA; Mehdipour P; Lun X; Chen HM; Mallard C; Hay AJ; Johnston MJ; Gafuik CJ; Zemp FJ; Shen Y; Ninkovic N; Osz K; Labit E; Berger ND; Brownsey DK; Kelly JJ; Biernaskie J; Dirks PB; Derksen DJ; Jones SJM; Senger DL; Chan JA; Mahoney DJ; De Carvalho DD; Gallo M
Nat Commun; 2023 May; 14(1):3062. PubMed ID: 37244935
[TBL] [Abstract][Full Text] [Related]
2. MLL5 Orchestrates a Cancer Self-Renewal State by Repressing the Histone Variant H3.3 and Globally Reorganizing Chromatin.
Gallo M; Coutinho FJ; Vanner RJ; Gayden T; Mack SC; Murison A; Remke M; Li R; Takayama N; Desai K; Lee L; Lan X; Park NI; Barsyte-Lovejoy D; Smil D; Sturm D; Kushida MM; Head R; Cusimano MD; Bernstein M; Clarke ID; Dick JE; Pfister SM; Rich JN; Arrowsmith CH; Taylor MD; Jabado N; Bazett-Jones DP; Lupien M; Dirks PB
Cancer Cell; 2015 Dec; 28(6):715-729. PubMed ID: 26626085
[TBL] [Abstract][Full Text] [Related]
3. Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC.
Zhang G; Dong Z; Prager BC; Kim LJ; Wu Q; Gimple RC; Wang X; Bao S; Hamerlik P; Rich JN
JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30779712
[TBL] [Abstract][Full Text] [Related]
4. The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma.
Kijewska M; Kocyk M; Kloss M; Stepniak K; Korwek Z; Polakowska R; Dabrowski M; Gieryng A; Wojtas B; Ciechomska IA; Kaminska B
Oncotarget; 2017 Mar; 8(10):16340-16355. PubMed ID: 28030801
[TBL] [Abstract][Full Text] [Related]
5. E2F and STAT3 provide transcriptional synergy for histone variant H2AZ activation to sustain glioblastoma chromatin accessibility and tumorigenicity.
Yoon J; Grinchuk OV; Tirado-Magallanes R; Ngian ZK; Tay EXY; Chuah YH; Lee BWL; Feng J; Crasta KC; Ong CT; Benoukraf T; Ong DST
Cell Death Differ; 2022 Jul; 29(7):1379-1394. PubMed ID: 35058574
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic modulation of metabolism in glioblastoma.
Dong Z; Cui H
Semin Cancer Biol; 2019 Aug; 57():45-51. PubMed ID: 30205139
[TBL] [Abstract][Full Text] [Related]
7. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
[TBL] [Abstract][Full Text] [Related]
8. ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways.
Wang F; Wang AY; Chesnelong C; Yang Y; Nabbi A; Thalappilly S; Alekseev V; Riabowol K
Oncogene; 2018 Jan; 37(3):286-301. PubMed ID: 28925404
[TBL] [Abstract][Full Text] [Related]
9. Glioma Stem-like Cells Keep Their H3.3 Variant Levels at Bay.
Becher OJ; Holland EC
Cancer Cell; 2015 Dec; 28(6):679-680. PubMed ID: 26678332
[TBL] [Abstract][Full Text] [Related]
10. Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.
Natsume A; Ito M; Katsushima K; Ohka F; Hatanaka A; Shinjo K; Sato S; Takahashi S; Ishikawa Y; Takeuchi I; Shimogawa H; Uesugi M; Okano H; Kim SU; Wakabayashi T; Issa JP; Sekido Y; Kondo Y
Cancer Res; 2013 Jul; 73(14):4559-70. PubMed ID: 23720055
[TBL] [Abstract][Full Text] [Related]
11. Differences among brain tumor stem cell types and fetal neural stem cells in focal regions of histone modifications and DNA methylation, broad regions of modifications, and bivalent promoters.
Yoo S; Bieda MC
BMC Genomics; 2014 Aug; 15(1):724. PubMed ID: 25163646
[TBL] [Abstract][Full Text] [Related]
12. Glioblastoma initiating cells are sensitive to histone demethylase inhibition due to epigenetic deregulation.
Mallm JP; Windisch P; Biran A; Gal Z; Schumacher S; Glass R; Herold-Mende C; Meshorer E; Barbus M; Rippe K
Int J Cancer; 2020 Mar; 146(5):1281-1292. PubMed ID: 31456217
[TBL] [Abstract][Full Text] [Related]
13. Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness.
Bogeas A; Morvan-Dubois G; El-Habr EA; Lejeune FX; Defrance M; Narayanan A; Kuranda K; Burel-Vandenbos F; Sayd S; Delaunay V; Dubois LG; Parrinello H; Rialle S; Fabrega S; Idbaih A; Haiech J; Bièche I; Virolle T; Goodhardt M; Chneiweiss H; Junier MP
Acta Neuropathol; 2018 Feb; 135(2):267-283. PubMed ID: 29149419
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between DNA methylation and histone acetylation triggers GDNF high transcription in glioblastoma cells.
Zhang B; Gu X; Han X; Gao Q; Liu J; Guo T; Gao D
Clin Epigenetics; 2020 Mar; 12(1):47. PubMed ID: 32183903
[TBL] [Abstract][Full Text] [Related]
15. Super Elongation Complex as a Targetable Dependency in Diffuse Midline Glioma.
Dahl NA; Danis E; Balakrishnan I; Wang D; Pierce A; Walker FM; Gilani A; Serkova NJ; Madhavan K; Fosmire S; Green AL; Foreman NK; Venkataraman S; Vibhakar R
Cell Rep; 2020 Apr; 31(1):107485. PubMed ID: 32268092
[TBL] [Abstract][Full Text] [Related]
16. A system for genome-wide histone variant dynamics in ES cells reveals dynamic MacroH2A2 replacement at promoters.
Yildirim O; Hung JH; Cedeno RJ; Weng Z; Lengner CJ; Rando OJ
PLoS Genet; 2014 Aug; 10(8):e1004515. PubMed ID: 25102063
[TBL] [Abstract][Full Text] [Related]
17. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
Li Q; Dong C; Cui J; Wang Y; Hong X
J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
[TBL] [Abstract][Full Text] [Related]
18. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.
Gao X; Jin W
Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866
[TBL] [Abstract][Full Text] [Related]
19. Loss of histone variant macroH2A2 expression associates with progression of anal neoplasm.
Hu WH; Miyai K; Sporn JC; Luo L; Wang JY; Cosman B; Ramamoorthy S
J Clin Pathol; 2016 Jul; 69(7):627-31. PubMed ID: 26658220
[TBL] [Abstract][Full Text] [Related]
20. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
